Shopping Cart

Close

No products in the cart.

LeadR Profile


Mariam Jamal-Hanjani
University College London Hospitals NHS Foundation Trust
United Kingdom

SLR Oncology ScienceLeadR Reputation 100%

Favorite Settings

Follow this Expert

Health Specialties

Main specialty  Oncology
Full career - Last 3 years

Main Topics

Publications and Clinical Trials


Publications - Clinical Trials

Education

Academic Background

Source: ORCID

Organization

all information about organizations

Source: Pubmed

University College London

Cancer Research UK

University College London Hospitals NHS Foundation Trust

St George’s University Hospitals NHS Foundation Trust

Guy's Hospital

Awards and Honors

Source: ORCID

Academic Societies

Source: ORCID

Publications Synthesis

Source: Pubmed

Number : 84

Citations

Citations: 6 898 1st author: 9 Last author: 4 Unique author: 0

Main journals

Nature 11
Nat Med 9
Cancer Discov 5
Cell 5
Ann Oncol 3

Best Journals

Nature 11
Nat Med 9
Cell 5

Breakdown by type

Historic per year



Main pathologies and trends

Publications List

Quick search selection

Source: Pubmed Source: OpenAlex
Title Journal CIT SLR Year
Embracing cancer complexity: Hallmarks of systemic disease. Cell
38552609
0 64.5 2024
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer. Cancer Discov
38581685
0 28.2 2024
The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma. Nat Cancer
38200244
0 22.7 2024
Research autopsy programmes in oncology: shared experience from 14 centres across the world. J Pathol
38551513
0 7.3 2024
Body composition and lung cancer-associated cachexia in TRACERx. Nat Med
37045997
2 82.9 2023
Evolutionary characterization of lung adenocarcinoma morphology in TRACERx. Nat Med
37045996
7 82.9 2023
Lung adenocarcinoma promotion by air pollutants. Nature
37020004
28 64.8 2023
Antibodies against endogenous retroviruses promote lung cancer immunotherapy. Nature
37046094
29 64.8 2023
The evolution of lung cancer and impact of subclonal selection in TRACERx. Nature
37046096
21 64.8 2023
Genomic-transcriptomic evolution in lung cancer and metastasis. Nature
37046093
9 64.8 2023
The evolution of non-small cell lung cancer metastases in TRACERx. Nature
37046095
17 64.8 2023
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA. Nature
37055640
14 64.8 2023
Cachexia: A systemic consequence of progressive, unresolved disease. Cell
37116469
4 64.5 2023
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance. Nat Genet
38049664
3 30.8 2023
Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways. Cancer Discov
36977461
4 28.2 2023
Insights into the metastatic cascade through research autopsies. Trends Cancer
37059687
2 18.4 2023
Copy number architectures define treatment-mediated selection of lethal prostate cancer clones. Nat Commun
37563129
1 16.6 2023
IFN-γ-dependent interactions between tissue-intrinsic γδ T cells and tissue-infiltrating CD8 T cells limit allergic contact dermatitis. J Allergy Clin Immunol
37562754
0 14.2 2023
Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma. Cancer Res
36853169
4 11.2 2023
Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series. J Cachexia Sarcopenia Muscle
37671529
3 8.9 2023
When can we be confident of surgical cure with ctDNA? Nat Rev Clin Oncol
35798966
2 78.8 2022
The translational challenges of precision oncology. Cancer Cell
35487215
13 50.3 2022
Targeted profiling of human extrachromosomal DNA by CRISPR-CATCH. Nat Genet
36253572
20 30.8 2022
A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer. Nat Cancer
35637401
21 22.7 2022
Spatiotemporal genomic analysis reveals distinct molecular features in recurrent stage I non-small cell lung cancers. Cell Rep
35830809
2 8.8 2022
Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay. NAR Cancer
35664542
3 0 2022
Using DNA sequencing data to quantify T cell fraction and therapy response. Nature
34497419
14 69.504 2021
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma. Cancer Cell
34715028
56 38.585 2021
Induction of APOBEC3 Exacerbates DNA Replication Stress and Chromosomal Instability in Early Breast and Lung Cancer Evolution. Cancer Discov
33947663
37 38.272 2021
Tracking Cancer Evolution through the Disease Course. Cancer Discov
33811124
38 38.272 2021
Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections. BMC Med
33902581
61 11.15 2021
Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists. Br J Cancer
34489586
3 9.075 2021
Optimising fusion detection through sequential DNA and RNA molecular profiling of non-small cell lung cancer. Lung Cancer
34536732
2 6.081 2021
Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers. Lancet
32653078
104 79.321 2020
Scalable and robust SARS-CoV-2 testing in an academic center. Nat Biotechnol
32555528
22 54.908 2020
Author Correction: Scalable and robust SARS-CoV-2 testing in an academic center. Nat Biotechnol
32681136
2 54.908 2020
Publisher Correction: Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer. Nat Med
32494063
1 53.44 2020
Publisher Correction: Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse. Nat Med
32494064
1 53.44 2020
Geospatial immune variability illuminates differential evolution of lung adenocarcinoma. Nat Med
32461698
74 53.44 2020
Publisher Correction: A clonal expression biomarker associates with lung cancer mortality. Nat Med
32494065
0 53.44 2020
Pervasive chromosomal instability and karyotype order in tumour evolution. Nature
32879494
94 49.962 2020
Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution. Nat Genet
32139907
71 38.33 2020
Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue. Cell Rep
32375028
28 9.423 2020
Transcriptome analysis of IPF fibroblastic foci identifies key pathways involved in fibrogenesis. Thorax
33214245
17 9.102 2020
Clinical outcomes of COVID-19 in long-term care facilities for people with epilepsy. Epilepsy Behav
33279440
7 3.337 2020
The T cell differentiation landscape is shaped by tumour mutations in lung cancer. Nat Cancer
32803172
35 0 2020
Neoantigen-directed immune escape in lung cancer evolution. Nature
30894752
316 42.779 2019
Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse. Nat Med
31591595
74 36.13 2019
A clonal expression biomarker associates with lung cancer mortality. Nat Med
31591602
34 36.13 2019
Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer. Nat Med
31591606
64 36.13 2019
Inactivation of RB1 and histological transformation in EGFR-mutant lung adenocarcinoma. Ann Oncol
31959334
1 32.976 2019
Cancer cachexia in thoracic malignancy: a narrative review. Curr Opin Support Palliat Care
31592847
3 1.618 2019
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal. Cell
29656895
274 36.216 2018
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal. Cell
29656894
242 36.216 2018
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies. Cancer Cell
29576375
263 23.916 2018
Genomic instability in mutant p53 cancer cells upon entotic engulfment. Nat Commun
30076358
39 11.878 2018
Publisher Correction: Genomic instability in mutant p53 cancer cells upon entotic engulfment. Nat Commun
30154405
1 11.878 2018
KRAS: Reasons for optimism in lung cancer. Eur J Cancer
29894909
27 6.68 2018
Tracking the Evolution of Non-Small-Cell Lung Cancer. N Engl J Med
28445112
893 79.258 2017
Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature
29258292
10 43.07 2017
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature
28445469
624 41.577 2017
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution. Cell
29107330
460 31.398 2017
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors. Immunity
28410988
174 19.734 2017
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science
26940869
1319 37.205 2016
Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer. Ann Oncol
26823523
73 11.855 2016
Extreme chromosomal instability forecasts improved outcome in ER-negative breast cancer: a prospective validation cohort study from the TACT trial. Ann Oncol
26003169
42 11.855 2015
Translational implications of tumor heterogeneity. Clin Cancer Res
25770293
219 9.619 2015
The Value of Patient and Public Involvement in Trial Design and Development. Clin Oncol (R Coll Radiol)
26184690
5 3.236 2015
TumorTracer: a method to identify the tissue of origin from the somatic mutations of a tumor specimen. BMC Med Genomics
26429708
28 2.848 2015
Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science
25301630
522 37.205 2014
An in vivo functional screen identifies ST6GalNAc2 sialyltransferase as a breast cancer metastasis suppressor. Cancer Discov
24520024
49 20.011 2014
Tracking genomic cancer evolution for precision medicine: the lung TRACERx study. PLoS Biol
25003521
82 9.797 2014
Implications of intratumour heterogeneity for treatment stratification. J Pathol
24115146
23 6.894 2014
Expression of regulators of mitotic fidelity are associated with intercellular heterogeneity and chromosomal instability in primary breast cancer. Breast Cancer Res Treat
25288231
5 3.626 2014
Taxane benefit in breast cancer--a role for grade and chromosomal stability. Nat Rev Clin Oncol
23648828
22 20.693 2013
Tumour heterogeneity and immune-modulation. Curr Opin Pharmacol
23664091
12 5.363 2013
Bone metastases in germ cell tumours: lessons learnt from a large retrospective study. BJU Int
23795785
16 4.439 2013
Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma. Acta Oncol
22943385
5 3.156 2012
Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of epidermal growth factor receptor-mutant non-small cell lung cancer metastatic to the brain. Clin Cancer Res
22167408
64 9.619 2011
Pharmacokinetic evaluation of pixantrone for the treatment of non-Hodgkin's lymphoma. Expert Opin Drug Metab Toxicol
21905966
1 3.027 2011
Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer. Future Oncol
21675836
15 2.131 2011
Laparoscopy: a tool for the diagnosis and treatment of omental torsion. Int J Clin Pract
19143867
1 2.14 2008
Increased prevalence of ventricular fibrillation in patients with type 2 diabetes mellitus. Heart Vessels
17653519
19 3.434 2007
Totally extra-peritoneal repair of inguinal hernia by a glove-balloon: technical innovation. Surgeon
17849960
1 2.558 2007

Clinical Trials 3 Source:  ClinicalTrials

Synthesis

By phase:

N/A 3

By status:

Recruiting 2
Active, not recruiting 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 1
multicentric5to9 1
multicentricup10 1

Main Topics

Female Urogenital Diseases and Pregnancy Complications 1
Male Urogenital Diseases 1
Respiratory Tract Diseases 1

Cohort/Consortium Investigators 2

Clinical Trials Timeline Source: ClinicalTrials

Studies Phases and Years

Clinical Trials List Source: ClinicalTrials

Quick search selection

NCTID - Title Phase Status Year

NCT03004755

The PEACE (Posthumous Evaluation of Advanced Cancer Environment) Study
N/A Recruiting 2014

NCT01888601

TRAcking Non small Cell Lung Cancer Evolution Through Therapy (Rx)
N/A Active, not recruiting 2014

NCT03226886

TRACERx Renal CAPTURE Sub study
N/A Recruiting 2012

LeadR Networks Source: Pubmed Source: ClinicalTrials

Main global connection map



Nb Contacts:
Country Contact count
United Kingdom 524
United States 84
Australia 21
Germany 15
Italy 12
Spain 12
Switzerland 12
France 9
Canada 7
Denmark 6
Sweden 4
Hungary 3
India 3
Ireland 3
Netherlands 3
Poland 3
Portugal 3
Brazil 2
Japan 2
New Zealand 2
Pakistan 2
Belgium 1
Malaysia 1
Nepal 1
Nigeria 1
Qatar 1
Russia 1
Saudi Arabia 1
Slovenia 1
South Africa 1
Tanzania 1
Thailand 1

LeadR Networks Source: Pubmed Source: ClinicalTrials

Graph connection

LeadR Networks Source: Pubmed Source: ClinicalTrials

Connection list

Name Organization Country Linked
Swanton Charles University College London Hospitals NHS Foundation Trust United Kingdom 25
Mc Granahan Nicholas University College London United Kingdom 11
Veeriah Selvaraju University College London United Kingdom 11
Quezada Sergio A University College London United Kingdom 10
Birkbak Nicolai J Aarhus University Hospital Denmark 10
Ward Sophia Imperial College London United Kingdom 10
Van Loo Peter The Francis Crick Institute United Kingdom 8
Falzon Mary University College London Hospitals NHS Foundation Trust United Kingdom 8
Blackhall Fiona Christie Hospital NHS Foundation Trust United Kingdom 8
Hackshaw Allan University College London United Kingdom 8
Naidu Babu University Hospitals Birmingham NHS Foundation Trust United Kingdom 8
Papadatos-Pastos Dionysis Princess Alexandra Hospital (United Kingdom) United Kingdom 8
Hynds Robert E University College London United Kingdom 8
Marafioti Teresa University College London Hospitals NHS Foundation Trust United Kingdom 8
Lee Siow Ming University College London Hospitals NHS Foundation Trust United Kingdom 8
Blyth Kevin G Cancer Research UK Beatson Institute United Kingdom 7
Navani Neal University College London United Kingdom 7
Middleton Gary University Hospitals Birmingham NHS Foundation Trust United Kingdom 7
Lester Jason F Singleton Hospital United Kingdom 7
Danson Sarah University of Sheffield United Kingdom 7
Stewart Aengus The Francis Crick Institute United Kingdom 7
Kanu Nnennaya University College London United Kingdom 7
Watkins Thomas B K University College London United Kingdom 7
Aerts Hugo J W L Massachusetts General Hospital United States 6
Shackcloth Michael Liverpool Heart and Chest Hospital NHS Trust United Kingdom 6